Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1989 August; 82(8): 458–461.
PMCID: PMC1292248

Plasma exchange for Guillain-Barré syndrome.


The impact of plasma exchange (PE) on the treatment of severe Guillain-Barré syndrome (GBS) was studied by comparing all the 16 patients treated with PE in a London teaching hospital between January 1985 and August 1987, with 64 historical controls drawn from a series of patients observed during a prospective study in South East England in 1983 and 1984. There were no GBS-related deaths in the PE treated group but seven in the historical controls (2P = 0.39). The median duration of ventilation was only 20 days (range 7-64) in the PE group compared with 36 days (range 14-365) in the surviving patients in the control group (2P = 0.06, 95% confidence interval of difference in medians -36 to 0 days). The PE group walked earlier without aid (median 55.5 compared with 86 days, 2P = 0.04, 95% confidence interval of difference in medians -88 to -2 days). Three months after the onset of neuropathy all PE treated patients were able to walk with support or better, whereas 19 of the surviving historical controls were unable to walk even with support (2P = 0.009). The costs of PE were offset by savings in intensive care unit and hospital expenditure.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (829K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cook SD, Dowling PC, Murray MR, Whitaker JN. Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol. 1971 Feb;24(2):136–144. [PubMed]
  • Cook SD, Dowling PC. the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Ann Neurol. 1981;9 (Suppl):70–79. [PubMed]
  • Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol. 1982 Jan;11(1):69–75. [PubMed]
  • Feasby TE, Hahn AF, Gilbert JJ. Passive transfer studies in Guillain-Barré polyneuropathy. Neurology. 1982 Oct;32(10):1159–1167. [PubMed]
  • Koski CL, Humphrey R, Shin ML. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc Natl Acad Sci U S A. 1985 Feb;82(3):905–909. [PubMed]
  • Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet. 1978 Nov 18;2(8099):1100–1100. [PubMed]
  • Rail D, Stark R, Swash M, Newland A. Improvement in nerve condition after plasma exchange for Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1980 Dec;43(12):1147–1147. [PMC free article] [PubMed]
  • Valbonesi M, Garelli S, Mosconi L, Zerbi D, Celano I. Plasma exchange as a therapy for Guillain-Barré syndrome with immune complexes. Vox Sang. 1981;41(2):74–78. [PubMed]
  • Durward WF, Burnett AK, Watkins R, Reid JM. Plasma exchange in Guillain-Barré syndrome. Br Med J (Clin Res Ed) 1981 Sep 19;283(6294):794–794. [PMC free article] [PubMed]
  • Osterman PO, Fagius J, Säfwenberg J, Danersund A, Wallin BG, Nordesjö LO. Treatment of the Guillain-Barré syndrome by plasmapheresis. Arch Neurol. 1982 Mar;39(3):148–154. [PubMed]
  • Gross ML, Legg NJ, Lockwood MC, Pallis C. The treatment of inflammatory polyneuropathy by plasma exchange. J Neurol Neurosurg Psychiatry. 1982 Aug;45(8):675–679. [PMC free article] [PubMed]
  • Kennard C, Newland AC, Ridley A. Treatment of the Guillain-Barré syndrome by plasma exchange. J Neurol Neurosurg Psychiatry. 1982 Sep;45(9):847–850. [PMC free article] [PubMed]
  • Tharakan J, Tandon M, Maheshwari MC. Plasmapheresis in acute infective polyneuritis. J Assoc Physicians India. 1982 Mar;30(3):155–156. [PubMed]
  • Greenwood RJ, Newsom-Davis J, Hughes RA, Aslan S, Bowden AN, Chadwick DW, Gordon NS, McLellan DL, Millac P, Stott RB, et al. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Apr 21;1(8382):877–879. [PubMed]
  • Osterman PO, Fagius J, Lundemo G, Pihlstedt P, Pirskanen R, Sidén A, Säfwenberg J. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Dec 8;2(8415):1296–1299. [PubMed]
  • Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988 May;51(5):605–612. [PMC free article] [PubMed]
  • Winer JB, Hughes RA, Greenwood RJ, Perkin GD, Healy MJ. Prognosis in Guillain-Barré syndrome. Lancet. 1985 May 25;1(8439):1202–1203. [PubMed]
  • Huestis DW. Mortality in therapeutic haemapheresis. Lancet. 1983 May 7;1(8332):1043–1043. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press